Disclosure Of Entity's Operating Segments [Text Block]

STADA Arzneimittel AG - Filing #6743034

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	—	—	3.249.451 EUR	—	3.010.315 EUR	—	—	—
Share of profit (loss) of associates and joint ventures accounted for using equity method	—	—	—	—	269,000 EUR	—	93,000 EUR	—	—	—
Tax expense (income)	—	—	—	—	68,565 EUR	—	38,593 EUR	—	—	—
Profit (loss) before tax	—	—	—	—	332,375 EUR	—	220,492 EUR	—	—	—
Profit (loss)	16,871 EUR	—	246,939 EUR	246,939 EUR	263,810 EUR	—	181,899 EUR	167,314 EUR	14,585 EUR	167,314 EUR
Assets	—	5.756.945 EUR	—	—	—	5.258.197 EUR	—	—	—	—
Investments accounted for using equity method	—	2,939 EUR	—	—	—	2,710 EUR	—	—	—	—
Cash flows from (used in) operating activities	—	—	—	—	598,245 EUR	—	405,890 EUR	—	—	—
Cash flows from (used in) investing activities	—	—	—	—	307,820 EUR	—	1.225.343 EUR	—	—	—
Cash flows from (used in) financing activities	—	—	—	—	35,314 EUR	—	886,509 EUR	—	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]